Frequency of achieving optimal reperfusion with thrombolysis in acute myocardial infarction (analysis of four German multicenter studies)

• Published in: The American journal of cardiology Vol. 74; no. 1; pp. 1 - 4
• Main Authors: Vogt, Albrecht, von Essen, Rainer, Tebbe, Ulrich, Feuerer, Werner, Appel, Karl-Friedrich, Niederer, Walter, Neuhaus, Karl-Ludwig
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.07.1994; Elsevier Limited
• Subjects: Adult; Aged; Anistreplase - pharmacology; Anistreplase - therapeutic use; Cardiovascular disease; Female; Fibrinolytic Agents - pharmacology; Fibrinolytic Agents - therapeutic use; Humans; Logistic Models; Male; Medical research; Middle Aged; Myocardial Infarction - drug therapy; Plasminogen Activators - pharmacology; Plasminogen Activators - therapeutic use; Recombinant Proteins - pharmacology; Recombinant Proteins - therapeutic use; Recurrence; Retrospective Studies; Thrombolytic Therapy; Tissue Plasminogen Activator - pharmacology; Tissue Plasminogen Activator - therapeutic use; Treatment Failure; Urokinase-Type Plasminogen Activator - pharmacology; Urokinase-Type Plasminogen Activator - therapeutic use; Vascular Patency - drug effects

Patients from 4 German multicenter studies on thrombolysis in acute myocardial infarction (AMI) were retrospectively evaluated to assess the incidence of optimal reperfusion, defined as a completely perfused infarct vessel after 90 minutes, without subsequent death or reinfarction, and without reocc...